Evidence map›Paper›PMID 32849586›Full record

ReviewFrontiers in immunology2020

Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond.

Guillermina Girardi, Joshua J Lingo, Sherry D Fleming, Jean F Regal

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 2 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Complement protein concentrations and activity in human cervical mucus.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Guillermina GirardiDepartment of Basic Medical Sciences, College of Medicine, Member of QU Health, Qatar University, Doha, Qatar.
Joshua J LingoDivision of Biology, Kansas State University, Manhattan, KS, United States.
Sherry D FlemingDivision of Biology, Kansas State University, Manhattan, KS, United States.
Jean F RegalDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, United States.
Kansas State University · USQatar University · QAUniversity of Minnesota, Duluth · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
Innate Immune Complement System and Developmental Programming of Functional β Cell MassR21HD100840 · NICHD · UNIVERSITY OF MINNESOTA · PI ALEJANDRO, EMILYN, REGAL, JEAN F. · 2020 to 2021
$425k
NICHD NIH HHS R21 HD100840NIGMS NIH HHS P20 GM103418
6 · The paper itself

Abstract

The complement cascade was identified over 100 years ago, yet investigation of its role in pregnancy remains an area of intense research. Complement inhibitors at the maternal-fetal interface prevent inappropriate complement activation to protect the fetus. However, this versatile proteolytic cascade also favorably influences numerous stages of pregnancy, including implantation, fetal development, and labor. Inappropriate complement activation in pregnancy can have adverse lifelong sequelae for both mother and child. This review summarizes the current understanding of complement activation during all stages of pregnancy. In addition, consequences of complement dysregulation during adverse pregnancy outcomes from miscarriage, preeclampsia, and pre-term birth are examined. Finally, future research directions into complement activation during pregnancy are considered.

Indexed as

Complement ActivationComplement System ProteinsEmbryo ImplantationFemaleFetal DevelopmentHumansParturitionPregnancyPregnancy ComplicationsComplement System Proteinscomplementfetal developmentinnate immunitypreeclampsiapregnancypregnancy losspreterm birth

Identifiers

PMID32849586
PMCPMC7411130
OpenAlexW3046446469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.